30 October 2026
30 October 2026
Sales for Eli Lilly’s Mounjaro and Zepbound topped $16bn, exceeding total revenue for many big pharma players.
The policy will allow compounders to use these actives in compounded medicines as wellness-focused peptides increasingly seep into the consumer market.
Dren Bio will use the capital to progress its broader pipeline in autoimmune disorders, immunology, neurology, and oncology.
Abrysvo was first approved in the US in 2023 for the prevention of lower respiratory tract disease (LRTD) caused by RSV.
The facility functions as the company's sole distribution centre in the US.
The UK Autumn Budget offered little in the way of new measures specifically for the life sciences sector, though incentives for early-stage businesses could help certain biotechs looking to establish themselves in Britain.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
